当前位置:首页 - 行情中心 - 嘉应制药(002198) - 财务分析 - 现金流量表

嘉应制药

(002198)

  

流通市值:32.07亿  总市值:32.07亿
流通股本:5.07亿   总股本:5.08亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金187,810,725.5676,106,582.41423,016,598.59318,611,884.37
  收到的税费返还93,641.65---
  收到其他与经营活动有关的现金52,073,554.7251,406,397.44,963,749.563,934,257.91
  经营活动现金流入小计239,977,921.93127,512,979.81427,980,348.15322,546,142.28
  购买商品、接受劳务支付的现金50,570,089.6719,801,918.82107,984,743.2892,032,003.89
  支付给职工以及为职工支付的现金28,523,781.8114,229,137.3353,695,997.7641,859,956.39
  支付的各项税费27,774,547.589,908,064.4345,548,445.0329,739,009.59
  支付其他与经营活动有关的现金158,494,858.395,407,614.06159,902,196.98140,623,371.04
  经营活动现金流出小计265,363,277.36139,346,734.64367,131,383.05304,254,340.91
  经营活动产生的现金流量净额-25,385,355.43-11,833,754.8360,848,965.118,291,801.37
二、投资活动产生的现金流量:
  收回投资收到的现金1,008,599.15---
  取得投资收益收到的现金1,714,177.5235,833.334,995,155.923,918,983.64
  处置固定资产、无形资产和其他长期资产收回的现金净额--894,595.73708,495.73
  处置子公司及其他营业单位收到的现金净额-1,435,878.37--
  收到的其他与投资活动有关的现金-16,533,898.431,179,990,000510,000,000
  投资活动现金流入小计2,722,776.6718,005,610.131,185,879,751.65514,627,479.37
  购建固定资产、无形资产和其他长期资产支付的现金18,913,056.367,352,833.2438,704,900.2434,133,902.24
  投资支付的现金29,505,606.6---
  支付其他与投资活动有关的现金-20,000,000979,990,000390,000,000
  投资活动现金流出小计48,418,662.9627,352,833.241,018,694,900.24424,133,902.24
  投资活动产生的现金流量净额-45,695,886.29-9,347,223.11167,184,851.4190,493,577.13
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金-025,401,080.4325,401,080.43
  支付其他与筹资活动有关的现金61,301,621.5350,000,000--
  筹资活动现金流出小计61,301,621.5350,000,00025,401,080.4325,401,080.43
  筹资活动产生的现金流量净额-61,301,621.53-50,000,000-25,401,080.43-25,401,080.43
四、汇率变动对现金及现金等价物的影响-1,062,500---
五、现金及现金等价物净增加额-133,445,363.25-71,180,977.94202,632,736.0883,384,298.07
  加:期初现金及现金等价物余额334,705,297336,141,154.38132,072,560.92133,506,919.66
  期末现金及现金等价物余额201,259,933.75264,960,176.44334,705,297216,891,217.73
补充资料:
  净利润20,082,559.48-20,611,599.55-
  资产减值准备1,296,086.72-5,220,582.22-
  固定资产和投资性房地产折旧10,517,543.55-18,304,790.56-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧10,517,543.55-18,304,790.56-
  无形资产摊销658,564.5-1,317,128.99-
  长期待摊费用摊销610,231.36-85,941.79-
  处置固定资产、无形资产和其他长期资产的损失1,085.59--1,606,951.4-
  固定资产报废损失--256,973.34-
  公允价值变动损失361,667.6---
  财务费用289,236.34-3,955.04-
  投资损失-415,663.13--675,010.43-
  递延所得税-1,613,122.36--924,086.7-
  其中:递延所得税资产减少-1,613,122.36--844,593.75-
    递延所得税负债增加---79,492.95-
  存货的减少1,983,857.38-360,088.94-
  经营性应收项目的减少-53,397,462.86-32,220,687.07-
  经营性应付项目的增加-5,759,939.6--14,326,733.87-
  现金的期末余额201,259,933.75-334,705,297-
  减:现金的期初余额334,705,297-132,072,560.92-
  现金及现金等价物的净增加额-133,445,363.25-202,632,736.08-
公告日期2025-08-262025-04-262025-04-262024-10-31
审计意见(境内)标准无保留意见
TOP↑